Laurus Labs Ltd vs Manipal Health Enterprises Ltd
A side-by-side comparison of Laurus Labs Ltd (LAURUSLABS) and Manipal Health Enterprises Ltd (MANIPALHOS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
Laurus Labs Ltd vs Manipal Health Enterprises Ltd are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation22
- Profitability22
- Growth02
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
MANIPALHOS takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
LAURUSLABS takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has been maintaining a healthy dividend payout of 19.0%"]
- − ["Stock is trading at 19.8 times its book value", "The company has delivered a poor sales growth of 7.19% over past five years.", "Company has a low return on equity of 10.1% over last 3 years.", "Company might be capitalizing the interest cost"]
- + ["Company has delivered good profit growth of 26.0% CAGR over last 5 years"]
- − ["Company has a low return on equity of 10.2% over last 3 years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.